Long-term symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol

被引：0
|
作者：
Kane, JM
Swyzen, W
Wu, XL
McQuade, R
Esteinou, RG
Van Tran, Q
Marcus, R
Crandall, D
机构：
[1] Zucker Hillside Hosp, Glen Oaks, NY USA
[2] Bristol Myers Squibb Co, US Med Affairs, Plainsboro, NJ USA
[3] Bristol Myers Squibb Co, Biostat & Data Management, Wallingford, CT 06492 USA
[4] Otsuka Pharmaceut Co Ltd, Global Med Affairs, Princeton, NJ USA
[5] Bristol Myers Squibb Co, Global Med Affairs, Lawrenceville, NJ USA
[6] Otsuka Pharmaceut Co Ltd, US Med Affairs, Rockville, MD USA
[7] Bristol Myers Squibb Co, Pharmaceut Res Inst, Global Clin Res, Wallingford, CT 06492 USA
[8] Bristol Myers Squibb Co, Neurosci, Plainsboro, NJ USA
来源：
BIOLOGICAL PSYCHIATRY | 2006年 / 59卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
394
引用
收藏
页码：121S / 121S
页数：1
相关论文
共 50 条
  • [31] The GiSAS study: Rationale and design of a pragmatic randomized controlled trial on aripiprazole, olanzapine and haloperidol in the long-term treatment of schizophrenia
    Parabiaghi, Alberto
    D'Avanzo, Barbara
    Tettamanti, Mauro
    Barbato, Angelo
    CONTEMPORARY CLINICAL TRIALS, 2011, 32 (05) : 675 - 684
  • [32] Effects of long-term aripiprazole therapy on the negative symptoms of schizophrenia
    Archibald, DG
    Manos, G
    Stock, E
    Jody, D
    Tourkodimitris, S
    Marcus, R
    Iwamoto, T
    Yamamoto, Y
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 155 - 155
  • [33] Long-term effects of aripiprazole therapy on the negative symptoms of schizophrenia
    Marder, S
    Archibald, D
    Manos, G
    Stock, E
    Jody, D
    Tourkodimitris, S
    Marcus, R
    Iwamoto, T
    Yamamoto, Y
    Carson, W
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S243 - S243
  • [34] Long-term tolerability and safety of aripiprazole in pediatric patients with schizophrenia or bipolar I disorder
    Nyilas, M.
    Correll, C.
    Werner, C.
    Forbes, R.
    Johnson, B.
    Aurang, C.
    Jin, N.
    Owen, R.
    Iwamoto, T.
    Carson, W.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 133 - 134
  • [35] Long-term remission in selected patients with pemphigus vulgaris treated with cyclosporine
    Mobini, N
    Padilla, T
    Ahmed, AR
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 36 (02) : 264 - 266
  • [36] Haloperidol versus atypical antipsychotics in the long-term treatment of schizophrenia
    Altamura, A. C.
    Buoli, M.
    Mauri, M. C.
    Dell'Osso, B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S466 - S466
  • [37] Type of symptom remission and treatment outcomes in the long-term treatment of patients with schizophrenia
    Ascher-Svanum, H
    Zhu, B
    Faries, DE
    Kinon, BJ
    Kane, JM
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 537 - 537
  • [38] Type of symptom remission and treatment outcomes in the long-term treatment of patients with schizophrenia
    Ascher-Svanum, H
    Zhu, BJ
    Faries, D
    Kinon, BJ
    Kane, JM
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S114 - S114
  • [39] Symptomatic remission and recovery in patients with schizophrenia
    Valencia, Marcelo
    Caraveo, Jorge
    Colin, Ricardo
    Verduzco, Wazcar
    Corona, Fernando
    SALUD MENTAL, 2014, 37 (01) : 59 - 74
  • [40] Beyond 52-Week Long-Term Safety: Long-Term Outcomes of Aripiprazole Lauroxil for Patients With Schizophrenia Continuing in an Extension Study
    Lauriello, John
    Claxton, Amy
    Du, Yangchun
    Weiden, Peter J.
    JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (05)
12345